@article{OPUS4-31409, title = {Electron and photon energy calibration with the ATLAS detector using 2015-2016 LHC proton-proton collision data}, series = {Journal of Instrumentation}, volume = {14}, journal = {Journal of Instrumentation}, organization = {The ATLAS Collaboration}, doi = {10.1088/1748-0221/14/03/P03017}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-314093}, pages = {1-58}, year = {2019}, abstract = {This paper presents the electron and photon energy calibration obtained with the ATLAS detector using about 36 fb(-1) of LHC proton-proton collision data recorded at root s = 13 TeV in 2015 and 2016. The different calibration steps applied to the data and the optimization of the reconstruction of electron and photon energies are discussed. The absolute energy scale is set using a large sample of Z boson decays into electron-positron pairs. The systematic uncertainty in the energy scale calibration varies between 0.03\% to 0.2\% in most of the detector acceptance for electrons with transverse momentum close to 45 GeV. For electrons with transverse momentum of 10 GeV the typical uncertainty is 0.3\% to 0.8\% and it varies between 0.25\% and 1\% for photons with transverse momentum around 60 GeV. Validations of the energy calibration with J/psi -> e(+)e(-) decays and radiative Z boson decays are also presented.}, language = {en} } @article{HartkeSprengerSahmetal.2019, author = {Hartke, Juliane and Sprenger, Philipp P. and Sahm, Jacqueline and Winterberg, Helena and Orivel, J{\´e}r{\^o}me and Baur, Hannes and Beuerle, Till and Schmitt, Thomas and Feldmeyer, Barbara and Menzel, Florian}, title = {Cuticular hydrocarbons as potential mediators of cryptic species divergence in a mutualistic ant association}, series = {Ecology and Evolution}, volume = {9}, journal = {Ecology and Evolution}, doi = {10.1002/ece3.5464}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-227857}, pages = {9160-9176}, year = {2019}, abstract = {Upon advances in sequencing techniques, more and more morphologically identical organisms are identified as cryptic species. Often, mutualistic interactions are proposed as drivers of diversification. Species of the neotropical parabiotic ant association between Crematogaster levior and Camponotus femoratus are known for highly diverse cuticular hydrocarbon (CHC) profiles, which in insects serve as desiccation barrier but also as communication cues. In the present study, we investigated the association of the ants' CHC profiles with genotypes and morphological traits, and discovered cryptic species pairs in both genera. To assess putative niche differentiation between the cryptic species, we conducted an environmental association study that included various climate variables, canopy cover, and mutualistic plant species. Although mostly sympatric, the two Camponotus species seem to prefer different climate niches. However in the two Crematogaster species, we could not detect any differences in niche preference. The strong differentiation in the CHC profiles may thus suggest a possible role during speciation itself either by inducing assortative mating or by reinforcing sexual selection after the speciation event. We did not detect any further niche differences in the environmental parameters tested. Thus, it remains open how the cryptic species avoid competitive exclusion, with scope for further investigations.}, language = {en} } @article{FrantzFalcaoPiresBalligandetal.2018, author = {Frantz, Stefan and Falcao-Pires, Ines and Balligand, Jean-Luc and Bauersachs, Johann and Brutsaert, Dirk and Ciccarelli, Michele and Dawson, Dana and de Windt, Leon J. and Giacca, Mauro and Hamdani, Nazha and Hilfiker-Kleiner, Denise and Hirsch, Emilio and Leite-Moreira, Adelino and Mayr, Manuel and Thum, Thomas and Tocchetti, Carlo G. and van der Velden, Jolanda and Varricchi, Gilda and Heymans, Stephane}, title = {The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC}, series = {European Journal of Heart Failure}, volume = {20}, journal = {European Journal of Heart Failure}, doi = {10.1002/ejhf.1138}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-229091}, pages = {445-459}, year = {2018}, abstract = {Activation of the immune system in heart failure (HF) has been recognized for over 20 years. Initially, experimental studies demonstrated a maladaptive role of the immune system. However, several phase III trials failed to show beneficial effects in HF with therapies directed against an immune activation. Preclinical studies today describe positive and negative effects of immune activation in HF. These different effects depend on timing and aetiology of HF. Therefore, herein we give a detailed review on immune mechanisms and their importance for the development of HF with a special focus on commonalities and differences between different forms of cardiomyopathies. The role of the immune system in ischaemic, hypertensive, diabetic, toxic, viral, genetic, peripartum, and autoimmune cardiomyopathy is discussed in depth. Overall, initial damage to the heart leads to disease specific activation of the immune system whereas in the chronic phase of HF overlapping mechanisms occur in different aetiologies.}, language = {en} } @article{deBoerDeKeulenaerBauersachsetal.2019, author = {de Boer, Rudolf A. and De Keulenaer, Gilles and Bauersachs, Johann and Brutsaert, Dirk and Cleland, John G. and Diez, Javier and Du, Xiao-Jun and Ford, Paul and Heinzel, Frank R. and Lipson, Kenneth E. and McDonagh, Theresa and Lopez-Andres, Natalia and Lunde, Ida G. and Lyon, Alexander R. and Pollesello, Piero and Prasad, Sanjay K. and Tocchetti, Carlo G. and Mayr, Manuel and Sluijter, Joost P. G. and Thum, Thomas and Tsch{\"o}pe, Carsten and Zannad, Faiez and Zimmermann, Wolfram-Hubertus and Ruschitzka, Frank and Filippatos, Gerasimos and Lindsey, Merry L. and Maack, Christoph and Heymans, Stephane}, title = {Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology}, series = {European Journal of Heart Failure}, volume = {21}, journal = {European Journal of Heart Failure}, doi = {10.1002/ejhf.1406}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-223613}, pages = {272-285}, year = {2019}, abstract = {Fibrosis is a pivotal player in heart failure development and progression. Measurements of (markers of) fibrosis in tissue and blood may help to diagnose and risk stratify patients with heart failure, and its treatment may be effective in preventing heart failure and its progression. A lack of pathophysiological insights and uniform definitions has hampered the research in fibrosis and heart failure. The Translational Research Committee of the Heart Failure Association discussed several aspects of fibrosis in their workshop. Early insidious perturbations such as subclinical hypertension or inflammation may trigger first fibrotic events, while more dramatic triggers such as myocardial infarction and myocarditis give rise to full blown scar formation and ongoing fibrosis in diseased hearts. Aging itself is also associated with a cardiac phenotype that includes fibrosis. Fibrosis is an extremely heterogeneous phenomenon, as several stages of the fibrotic process exist, each with different fibrosis subtypes and a different composition of various cells and proteins — resulting in a very complex pathophysiology. As a result, detection of fibrosis, e.g. using current cardiac imaging modalities or plasma biomarkers, will detect only specific subforms of fibrosis, but cannot capture all aspects of the complex fibrotic process. Furthermore, several anti-fibrotic therapies are under investigation, but such therapies generally target aspecific aspects of the fibrotic process and suffer from a lack of precision. This review discusses the mechanisms and the caveats and proposes a roadmap for future research.}, language = {en} } @article{KoenigZundelKrimmeretal.2019, author = {K{\"o}nig, Kerstin and Zundel, Petra and Krimmer, Elena and K{\"o}nig, Christian and Pollmann, Marie and Gottlieb, Yuval and Steidle, Johannes L. M.}, title = {Reproductive isolation due to prezygotic isolation and postzygotic cytoplasmic incompatibility in parasitoid wasps}, series = {Ecology and Evolution}, volume = {9}, journal = {Ecology and Evolution}, doi = {10.1002/ece3.5588}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-222796}, pages = {10694-10706}, year = {2019}, abstract = {The reproductive barriers that prevent gene flow between closely related species are a major topic in evolutionary research. Insect clades with parasitoid lifestyle are among the most species-rich insects and new species are constantly described, indicating that speciation occurs frequently in this group. However, there are only very few studies on speciation in parasitoids. We studied reproductive barriers in two lineages of Lariophagus distinguendus (Chalcidoidea: Hymenoptera), a parasitoid wasp of pest beetle larvae that occur in human environments. One of the two lineages occurs in households preferably attacking larvae of the drugstore beetle Stegobium paniceum ("DB-lineage"), the other in grain stores with larvae of the granary weevil Sitophilus granarius as main host ("GW-lineage"). Between two populations of the DB-lineage, we identified slight sexual isolation as intraspecific barrier. Between populations from both lineages, we found almost complete sexual isolation caused by female mate choice, and postzygotic isolation, which is partially caused by cytoplasmic incompatibility induced by so far undescribed endosymbionts which are not Wolbachia or Cardinium. Because separation between the two lineages is almost complete, they should be considered as separate species according to the biological species concept. This demonstrates that cryptic species within parasitoid Hymenoptera also occur in Central Europe in close contact to humans.}, language = {en} } @article{KendallRaderGagicetal.2019, author = {Kendall, Liam K. and Rader, Romina and Gagic, Vesna and Cariveau, Daniel P. and Albrecht, Matthias and Baldock, Katherine C. R. and Freitas, Breno M. and Hall, Mark and Holzschuh, Andrea and Molina, Francisco P. and Morten, Joanne M. and Pereira, Janaely S. and Portman, Zachary M. and Roberts, Stuart P. M. and Rodriguez, Juanita and Russo, Laura and Sutter, Louis and Vereecken, Nicolas J. and Bartomeus, Ignasi}, title = {Pollinator size and its consequences: Robust estimates of body size in pollinating insects}, series = {Ecology and Evolution}, volume = {9}, journal = {Ecology and Evolution}, doi = {10.1002/ece3.4835}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-325705}, pages = {1702-1714}, year = {2019}, abstract = {Body size is an integral functional trait that underlies pollination-related ecological processes, yet it is often impractical to measure directly. Allometric scaling laws have been used to overcome this problem. However, most existing models rely upon small sample sizes, geographically restricted sampling and have limited applicability for non-bee taxa. Allometric models that consider biogeography, phylogenetic relatedness, and intraspecific variation are urgently required to ensure greater accuracy. We measured body size as dry weight and intertegular distance (ITD) of 391 bee species (4,035 specimens) and 103 hoverfly species (399 specimens) across four biogeographic regions: Australia, Europe, North America, and South America. We updated existing models within a Bayesian mixed-model framework to test the power of ITD to predict interspecific variation in pollinator dry weight in interaction with different co-variates: phylogeny or taxonomy, sexual dimorphism, and biogeographic region. In addition, we used ordinary least squares regression to assess intraspecific dry weight ~ ITD relationships for ten bees and five hoverfly species. Including co-variates led to more robust interspecific body size predictions for both bees and hoverflies relative to models with the ITD alone. In contrast, at the intraspecific level, our results demonstrate that the ITD is an inconsistent predictor of body size for bees and hoverflies. The use of allometric scaling laws to estimate body size is more suitable for interspecific comparative analyses than assessing intraspecific variation. Collectively, these models form the basis of the dynamic R package, "pollimetry," which provides a comprehensive resource for allometric pollination research worldwide.}, language = {en} } @article{HillaertHovestadtVandegehuchteetal.2018, author = {Hillaert, Jasmijn and Hovestadt, Thomas and Vandegehuchte, Martijn L. and Bonte, Dries}, title = {Size-dependent movement explains why bigger is better in fragmented landscapes}, series = {Ecology and Evolution}, volume = {8}, journal = {Ecology and Evolution}, doi = {10.1002/ece3.4524}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-320322}, pages = {10754-10767}, year = {2018}, abstract = {Body size is a fundamental trait known to allometrically scale with metabolic rate and therefore a key determinant of individual development, life history, and consequently fitness. In spatially structured environments, movement is an equally important driver of fitness. Because movement is tightly coupled with body size, we expect habitat fragmentation to induce a strong selection pressure on size variation across and within species. Changes in body size distributions are then, in turn, expected to alter food web dynamics. However, no consensus has been reached on how spatial isolation and resource growth affect consumer body size distributions. Our aim was to investigate how these two factors shape the body size distribution of consumers under scenarios of size-dependent and size-independent consumer movement by applying a mechanistic, individual-based resource-consumer model. We also assessed the consequences of altered body size distributions for important ecosystem traits such as resource abundance and consumer stability. Finally, we determined those factors that explain most variation in size distributions. We demonstrate that decreasing connectivity and resource growth select for communities (or populations) consisting of larger species (or individuals) due to strong selection for the ability to move over longer distances if the movement is size-dependent. When including size-dependent movement, intermediate levels of connectivity result in increases in local size diversity. Due to this elevated functional diversity, resource uptake is maximized at the metapopulation or metacommunity level. At these intermediate levels of connectivity, size-dependent movement explains most of the observed variation in size distributions. Interestingly, local and spatial stability of consumer biomass is lowest when isolation and resource growth are high. Finally, we highlight that size-dependent movement is of vital importance for the survival of populations or communities within highly fragmented landscapes. Our results demonstrate that considering size-dependent movement is essential to understand how habitat fragmentation and resource growth shape body size distributions—and the resulting metapopulation or metacommunity dynamics—of consumers.}, language = {en} } @article{NolteHermannLingenPlatscheketal.2019, author = {Nolte, Kathleen and Hermann-Lingen, Christoph and Platschek, Lars and Holzendorf, Volker and Pilz, Stefan and Tomaschitz, Andreas and D{\"u}ngen, Hans-Dirk and Angermann, Christiane E. and Hasenfuß, Gerd and Pieske, Burkert and Wachter, Rolf and Edelmann, Frank}, title = {Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction}, series = {ESC Heart Failure}, volume = {6}, journal = {ESC Heart Failure}, doi = {10.1002/ehf2.12413}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-232303}, pages = {262-270}, year = {2019}, abstract = {Aims Vitamin D deficiency is prevalent in heart failure (HF), but its relevance in early stages of heart failure with preserved ejection fraction (HFpEF) is unknown. We tested the association of 25-hydroxyvitamin D [25(OH)D] serum levels with mortality, hospitalizations, cardiovascular risk factors, and echocardiographic parameters in patients with asymptomatic diastolic dysfunction (DD) or newly diagnosed HFpEF. Methods and results We measured 25(OH)D serum levels in outpatients with risk factors for DD or history of HF derived from the DIAST-CHF study. Participants were comprehensively phenotyped including physical examination, echocardiography, and 6 min walk test and were followed up to 5 years. Quality of life was evaluated by the Short Form 36 (SF-36) questionnaire. We included 787 patients with available 25(OH)D levels. Median 25(OH)D levels were 13.1 ng/mL, mean E/e′ medial was 13.2, and mean left ventricular ejection fraction was 59.1\%. Only 9\% (n = 73) showed a left ventricular ejection fraction <50\%. Fifteen per cent (n = 119) of the recruited participants had symptomatic HFpEF. At baseline, participants with 25(OH)D levels in the lowest tertile (≤10.9 ng/L; n = 263) were older, more often symptomatic (oedema and fatigue, all P ≤ 0.002) and had worse cardiac [higher N-terminal pro-brain natriuretic peptide (NT-proBNP) and left atrial volume index, both P ≤ 0.023], renal (lower glomerular filtration rate, P = 0.012), metabolic (higher uric acid levels, P < 0.001), and functional (reduced exercise capacity, 6 min walk distance, and SF-36 physical functioning score, all P < 0.001) parameters. Increased NT-proBNP, uric acid, and left atrial volume index and decreased SF-36 physical functioning scores were independently associated with lower 25(OH)D levels. There was a higher risk for lower 25(OH)D levels in association with HF, DD, and atrial fibrillation (all P ≤ 0.004), which remained significant after adjusting for age. Lower 25(OH)D levels (per 10 ng/mL decrease) tended to be associated with higher 5 year mortality, P = 0.05, hazard ratio (HR) 1.55 [1.00; 2.42]. Furthermore, lower 25(OH)D levels (per 10 ng/mL decrease) were related to an increased rate of cardiovascular hospitalizations, P = 0.023, HR = 1.74 [1.08; 2.80], and remained significant after adjusting for age, P = 0.046, HR = 1.63 [1.01; 2.64], baseline NT-proBNP, P = 0.048, HR = 1.62 [1.01; 2.61], and other selected baseline characteristics and co-morbidities, P = 0.043, HR = 3.60 [1.04; 12.43]. Conclusions Lower 25(OH)D levels were associated with reduced functional capacity in patients with DD or HFpEF and were significantly predictive for an increased rate of cardiovascular hospitalizations, also after adjusting for age, NT-proBNP, and selected baseline characteristics and co-morbidities.}, language = {en} } @article{BavendiekBerlinerAguirreDavilaetal.2019, author = {Bavendiek, Udo and Berliner, Dominik and Aguirre D{\´a}vila, Lukas and Schwab, Johannes and Maier, Lars and Philipp, Sebastian A. and Rieth, Andreas and Westenfeld, Ralf and Piorkowski, Christopher and Weber, Kristina and H{\"a}nselmann, Anja and Oldhafer, Maximiliane and Schallhorn, Sven and von der Leyen, Heiko and Schr{\"o}der, Christoph and Veltmann, Christian and St{\"o}rk, Stefan and B{\"o}hm, Michael and Koch, Armin and Bauersachs, Johann}, title = {Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study}, series = {European Journal of Heart Failure}, volume = {21}, journal = {European Journal of Heart Failure}, organization = {DIGIT-HF Investigators and Committees}, doi = {10.1002/ejhf.1452}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-221548}, pages = {676-684}, year = {2019}, abstract = {Aims Despite recent advances in the treatment of chronic heart failure (HF), mortality and hospitalizations still remain high. Additional therapies to improve mortality and morbidity are urgently needed. The efficacy of cardiac glycosides - although regularly used for HF treatment - remains unclear. DIGIT-HF was designed to demonstrate that digitoxin on top of standard of care treatment improves mortality and morbidity in patients with HF and a reduced ejection fraction (HFrEF). Methods Patients with chronic HF, New York Heart Association (NYHA) functional class III-IV and left ventricular ejection fraction (LVEF) ≤ 40\%, or patients in NYHA functional class II and LVEF ≤ 30\% are randomized 1:1 in a double-blind fashion to treatment with digitoxin (target serum concentration 8-18 ng/mL) or matching placebo. Randomization is stratified by centre, sex, NYHA functional class (II, III, or IV), atrial fibrillation, and treatment with cardiac glycosides at baseline. A total of 2190 eligible patients will be included in this clinical trial (1095 per group). All patients receive standard of care treatment recommended by expert guidelines upon discretion of the treating physician. The primary outcome is a composite of all-cause mortality or hospital admission for worsening HF (whatever occurs first). Key secondary endpoints are all-cause mortality, hospital admission for worsening HF, and recurrent hospital admission for worsening HF. Conclusion The DIGIT-HF trial will provide important evidence, whether the cardiac glycoside digitoxin reduces the risk for all-cause mortality and/or hospital admission for worsening HF in patients with advanced chronic HFrEF on top of standard of care treatment.}, language = {en} } @phdthesis{Hinsch2024, author = {Hinsch, Jan Per}, title = {Die Geschichte der Metalllegierungen in der zahn{\"a}rztlichen Prothetik und Technologie}, doi = {10.25972/OPUS-37128}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-371285}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2024}, abstract = {Die vorliegende Promotionsstudie leistet durch Gewinnung neuer Erkenntnisse zur zahnmedizinisch (technik-)historischen Forschung mittels der Erarbeitung und Darstellung einer chronologisch geordneten Entwicklungsgeschichte der zahn{\"a}rztlich-prothetisch verwendeten Metalllegierungen sowie ihrer dentalen Technologie einen eigenst{\"a}ndigen Forschungsbeitrag und tr{\"a}gt damit zu neuen Erkenntnissen in der zahnmedizinisch-historischen Forschung bei. Als problematisch stellte sich zu Beginn des 19. Jahrhunderts die Kunst des Legierens selbst heraus. So legierten und fertigten die Zahn{\"a}rzte ihre Metalllegierungen bis zum Ende des 19. Jahrhunderts meistens noch selbst, bedienten sich an vorlegierten Dukatengoldlegierungen oder beauftragten Goldschmiede. Diverse n{\"u}tzliche Legierungskompositionen wurden schriftlich von Pionieren der Zahnheilkunde und den ersten, erfahrensten Prothetikern dieser Zeit in deren fr{\"u}hen Lehrb{\"u}chern und Ver{\"o}ffentlichungen festgehalten und damit der breiten Zahn{\"a}rzteschaft zug{\"a}nglich gemacht. Mit ihrem Engagement wurde der Weg von der Empirie nicht nur bis zur Verwissenschaftlichung der Zahnmedizin geebnet, sondern zugleich der Fortschritt der dentalen Materialwissenschaft und besonders der Verarbeitungstechnologie dentaler Metalllegierungen eingel{\"a}utet. Erst zu Beginn des 20. Jahrhunderts etablierte sich durch Forschung und Vernetzung von Chemie, Metallurgie, Industrie und Zahnmedizin eine sach- und fachkundige zahn{\"a}rztliche Werkstoffkunde mit speziellen prothetisch geeigneten Metalllegierungen. Die verschiedenen Typenbezeichnungen Goldersatzlegierungen, Austauschlegierungen, Alternativlegierungen oder Aufbrennlegierungen waren in jeder Epoche einem tiefgreifenden Wandel unterworfen und charakteristisch f{\"u}r die jeweilige Zeit. Eine wichtige Erkenntnis aus dieser Studie ist, dass politisch-{\"o}konomische Ver{\"a}nderungen, insbesondere schwankende Edelmetallpreise, Inflation, politische Beschr{\"a}nkungen aufgrund von (vor-)kriegswirtschaftlichen Sparmaßnahmen sowie Gesundheitsreformen und Kostend{\"a}mpfungsgesetze einen erheblichen Einfluss auf die Zahn{\"a}rzte und die zahnmedizinisch-prothetische Rehabilitation ihrer Patienten hatte. Die indikationsgerechte Metalllegierungsauswahl und die damit verbundenen optimalen Materialeigenschaften f{\"u}r Zahnersatz und Patienten stellten Zahn{\"a}rzte damals wie heute vor eine Herausforderung.}, subject = {Prothetik}, language = {de} }